As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
North America was a leading market for anti-fibrinolytic drugs in the historical period and is expected to continue the trend over the forecast period. This dominance of the region can be correlated to the rising adoption of the drug in gynaecology. Based on types, lysteda (a tranexamic acid derivative) is one of the most common anti-fibrinolytic drug used for menorrhagia.
Anti-fibrinolytic drugs are used for the treatment of trauma, which is reported to be the major cause of death across the globe. Haemophilia A and B, platelet dysfunctions, and various other bleeding disorders also require anti-fibrinolytic drugs to inhibit fibrinolysis. The rising health awareness regarding these ailments is expected to aid the anti-fibrinolytic drugs industry growth in the coming years.
Pfizer Inc. (NYSE: PFE) is one of the prominent players in the anti-fibrinolytic drug industry. The company manufactures Cyklokapron, which is one of the widely used anti-fibrinolytic drugs across the industry. Alongside Pfizer Inc., other key market players, like Sanofi SA (NASDAQ: SNY), have invested in anti-fibrinolytic drug research, which is expected to aid the market growth in the forecast period. Rising investments, along with the increasing road accidents, are also predicted to provide a significant boost to the market growth in the coming years.
Market Analysis by Form, Type, Indication, End Use, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global anti-fibrinolytic drugs market are Pfizer Inc., Sanofi SA, Akorn, Inc, Cadila Healthcare Ltd., and Takeda Pharmaceutical Company Limited, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.